AVIR
Price
$2.72
Change
-$0.04 (-1.45%)
Updated
May 9 closing price
Capitalization
232.78M
2 days until earnings call
IVVD
Price
$0.65
Change
+$0.06 (+10.17%)
Updated
May 9 closing price
Capitalization
77.51M
2 days until earnings call
Ad is loading...

AVIR vs IVVD

Header iconAVIR vs IVVD Comparison
Open Charts AVIR vs IVVDBanner chart's image
Atea Pharmaceuticals
Price$2.72
Change-$0.04 (-1.45%)
Volume$372.62K
Capitalization232.78M
Invivyd
Price$0.65
Change+$0.06 (+10.17%)
Volume$1.2M
Capitalization77.51M
AVIR vs IVVD Comparison Chart
Loading...
AVIR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IVVD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AVIR vs. IVVD commentary
May 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AVIR is a Hold and IVVD is a Hold.

Ad is loading...
COMPARISON
Comparison
May 10, 2025
Stock price -- (AVIR: $2.72 vs. IVVD: $0.65)
Brand notoriety: AVIR and IVVD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AVIR: 101% vs. IVVD: 62%
Market capitalization -- AVIR: $232.78M vs. IVVD: $77.51M
AVIR [@Biotechnology] is valued at $232.78M. IVVD’s [@Biotechnology] market capitalization is $77.51M. The market cap for tickers in the [@Biotechnology] industry ranges from $296.96B to $0. The average market capitalization across the [@Biotechnology] industry is $2.13B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AVIR’s FA Score shows that 0 FA rating(s) are green whileIVVD’s FA Score has 1 green FA rating(s).

  • AVIR’s FA Score: 0 green, 5 red.
  • IVVD’s FA Score: 1 green, 4 red.
According to our system of comparison, both AVIR and IVVD are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AVIR’s TA Score shows that 4 TA indicator(s) are bullish while IVVD’s TA Score has 5 bullish TA indicator(s).

  • AVIR’s TA Score: 4 bullish, 6 bearish.
  • IVVD’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, IVVD is a better buy in the short-term than AVIR.

Price Growth

AVIR (@Biotechnology) experienced а -8.72% price change this week, while IVVD (@Biotechnology) price change was +2.82% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.25%. For the same industry, the average monthly price growth was +9.40%, and the average quarterly price growth was -13.49%.

Reported Earning Dates

AVIR is expected to report earnings on Aug 06, 2025.

IVVD is expected to report earnings on Aug 19, 2025.

Industries' Descriptions

@Biotechnology (-6.25% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AVIR($233M) has a higher market cap than IVVD($77.5M). IVVD YTD gains are higher at: 45.814 vs. AVIR (-18.806). IVVD has higher annual earnings (EBITDA): -173.76M vs. AVIR (-192.53M). AVIR has more cash in the bank: 455M vs. IVVD (69.3M). IVVD has less debt than AVIR: IVVD (1.3M) vs AVIR (1.64M). IVVD has higher revenues than AVIR: IVVD (25.4M) vs AVIR (0).
AVIRIVVDAVIR / IVVD
Capitalization233M77.5M301%
EBITDA-192.53M-173.76M111%
Gain YTD-18.80645.814-41%
P/E RatioN/AN/A-
Revenue025.4M-
Total Cash455M69.3M657%
Total Debt1.64M1.3M126%
FUNDAMENTALS RATINGS
AVIR: Fundamental Ratings
AVIR
OUTLOOK RATING
1..100
54
VALUATION
overvalued / fair valued / undervalued
1..100
46
Fair valued
PROFIT vs RISK RATING
1..100
97
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
61
P/E GROWTH RATING
1..100
96
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AVIRIVVD
RSI
ODDS (%)
Bullish Trend 2 days ago
64%
Bullish Trend 2 days ago
79%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
72%
Momentum
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 13 days ago
77%
Bullish Trend 2 days ago
81%
Declines
ODDS (%)
Bearish Trend 4 days ago
80%
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
78%
View a ticker or compare two or three
Ad is loading...
AVIR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IVVD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TSLA298.2613.44
+4.72%
Tesla
GME27.540.76
+2.84%
GameStop Corp
AAPL198.531.04
+0.53%
Apple
SPY564.34-0.72
-0.13%
SPDR® S&P 500® ETF
BTC.X102970.850000-270.609380
-0.26%
Bitcoin cryptocurrency

AVIR and

Correlation & Price change

A.I.dvisor indicates that over the last year, AVIR has been loosely correlated with IMNM. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if AVIR jumps, then IMNM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVIR
1D Price
Change %
AVIR100%
-1.45%
IMNM - AVIR
47%
Loosely correlated
-3.24%
HEPA - AVIR
47%
Loosely correlated
-0.61%
FHTX - AVIR
45%
Loosely correlated
-7.28%
KALV - AVIR
43%
Loosely correlated
-2.38%
MGTX - AVIR
42%
Loosely correlated
-0.91%
More

IVVD and

Correlation & Price change

A.I.dvisor indicates that over the last year, IVVD has been loosely correlated with ENTO. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is some statistical probability that if IVVD jumps, then ENTO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IVVD
1D Price
Change %
IVVD100%
+9.51%
ENTO - IVVD
66%
Loosely correlated
+5.09%
GHRS - IVVD
40%
Loosely correlated
-3.89%
ATAI - IVVD
38%
Loosely correlated
-0.71%
AVIR - IVVD
32%
Poorly correlated
-1.45%
CELC - IVVD
32%
Poorly correlated
-3.61%
More